Please ensure Javascript is enabled for purposes of website accessibility
US to Resume J&J COVID Vaccinations Despite Rare Clot Risk
gvw_ap_news
By Associated Press
Published 4 years ago on
April 24, 2021

Share

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnsonโ€™s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.

The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.

But ultimately Friday, the Food and Drug Administration and Centers for Disease Control and Prevention decided that J&Jโ€™s one-and-done vaccine is critical to fight the pandemic โ€” and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.

โ€œAbove all else, health and safety are at the forefront of our decisions,โ€ CDC Director Dr. Rochelle Walensky said in a statement. โ€œOur vaccine safety systems are working. We identified exceptionally rare events โ€“ out of millions of dosesโ€ of the J&J shot and will continue to monitor them.

Concerns About the Risk in Certain Age Groups of Women

The U.S. decision โ€” similar to how European regulators are rolling out J&Jโ€™s shot โ€” comes after CDC advisers earlier Friday voted 10-4 to resume vaccinations but panelists made clear that they must come with warnings about the risk. The group debated but ultimately steered clear of outright age restrictions.

โ€œThis is an age group that is most at risk (of the clotting) that is getting vaccine predominately to save other peoplesโ€™ lives and morbidity, not their own. And I think we have a responsibility to be certain that they know this,โ€ said Dr. Sarah Long of Drexel University College of Medicine, who voted against the proposal because she felt it did not go far enough in warning women.

The committee members all agreed the J&J vaccine โ€œshould be put back into circulation,โ€ panel chairman Dr. Jose Romero, Arkansasโ€™ health secretary, said in an interview after the vote. โ€œThe difference was how you convey the risk โ€ฆ It does not absolve us from making sure that people who receive this vaccine, if they are in the risk group, that we inform them of that.โ€

European regulators earlier this week made a similar decision, deciding the clot risk was small enough to allow the rollout of J&Jโ€™s shot. But how Americans ultimately handle J&Jโ€™s vaccine will influence other countries that donโ€™t have as much access to other vaccination options.

Dr. Paul Stoffels, J&Jโ€™s chief scientific officer, pledged that the company would work with U.S. and global authorities โ€œto ensure this very rare event can be identified early and treated effectively.โ€ J&J already was working with the FDA on a warning label for the shot.

Rare Blood Clot Cases

At issue is a weird kind of blood clot that forms in unusual places, such as veins that drain blood from the brain, and in patients with abnormally low levels of the platelets that form clots. Symptoms of the unusual clots, dubbed โ€œthrombosis with thrombocytopenia syndrome,โ€ include severe headaches a week or two after the J&J vaccination โ€” not right away โ€” as well as abdominal pain, nausea.

The government initially spotted six cases of the rare clots, with nine more cases coming to light in the last week or so. But even the first needle-in-a-haystack reports raised alarm because European regulators already had uncovered similar rare clots among recipients of another COVID-19 vaccine, from AstraZeneca. The AstraZeneca and J&J shots, while not identical, are made with the same technology.

European scientists found clues that an abnormal platelet-harming immune response to AstraZenecaโ€™s vaccine might be to blame โ€” and if so, then doctors should avoid the most common clot treatment, a blood thinner called heparin.

That added to U.S. authoritiesโ€™ urgency in pausing J&J vaccinations so they could tell doctors how to diagnose and treat these rare clots. Six patients were treated with heparin before anyone realized that might harm instead of help.

Determining if the Benefits Outweigh the Risks

Dr. Jesse Goodman of Georgetown University closely watched Fridayโ€™s deliberations and said people should be made aware of the clotting risk but that it shouldnโ€™t overshadow the benefits of COVID-19 protection.

โ€œWe need to treat people as adults, tell them what the information is and give them these choices,โ€ said Goodman, a former vaccine specialist at the FDA.

Two-dose vaccines from Pfizer and Moderna, which are made differently and havenโ€™t been linked to clot risks, are the mainstay of the U.S. vaccination effort. But many states had been counting on the easier-to-store, one-and-done option to also help protect hard-to-reach populations including people who are homeless or disabled.

The CDCโ€™s advisers struggled to put the rare clot cases into perspective. COVID-19 itself can cause a different type of blood clots. So can everyday medications, such as birth control pills.

The side effect debate isnโ€™t the only hurdle facing J&J. The FDA separately uncovered manufacturing violations at a Baltimore factory the company had hired to help brew the vaccine. No shots made by Emergent BioSciences have been used โ€” J&Jโ€™s production so far has come from Europe. But itโ€™s unclear how the idled factory will impact J&Jโ€™s pledge to provide 100 million U.S. vaccine doses by the end of May and 1 billion doses globally this year.

RELATED TOPICS:

DON'T MISS

Bravesโ€™ Jurickson Profar Hit With 80-Game PED Ban

UP NEXT

Conservative Pundit, ex-Secret Service Agent Dan Bongino Picked as FBI Deputy Director

Heading to Sierra? Prepare for Heavy Snow

9 hours ago

Mexican National Caught in Fresno County Pleads Guilty to Fentanyl Trafficking

9 hours ago

Bravesโ€™ Jurickson Profar Hit With 80-Game PED Ban

NEW YORK โ€” Atlanta Braves outfielder Jurickson Profar has been suspended for 80 games without pay for performance-enhancing drug use. Major ...

7 hours ago

Jurickson Profar
7 hours ago

Bravesโ€™ Jurickson Profar Hit With 80-Game PED Ban

8 hours ago

Watch: City Demolishes Historic Chinatown Building to Make Way for Housing

Photo of First Lady Melania Trump
8 hours ago

The Mystery of Melania Trumpโ€™s Wedding Dress and an eBay Sale

9 hours ago

Heading to Sierra? Prepare for Heavy Snow

Miguel Obed Romero Reyes, 25, of Sinaloa, Mexico, pleaded guilty Monday, March 31, 2025, to trafficking more than 200,000 fentanyl pills after authorities seized the drugs during a traffic stop on Interstate 5. (DOJ)
9 hours ago

Mexican National Caught in Fresno County Pleads Guilty to Fentanyl Trafficking

9 hours ago

CA Snowpack Is Near-Average. What Does This Mean for Water Supplies?

10 hours ago

Shohei Ohtani Adds Another No. 1 to His Resume: MLBโ€™s Best-Selling Jersey

Philadelphia Eagles quarterback Jalen Hurts (1) lines up for the goal line Tush Push play during the NFL championship playoff football game against the Washington Commanders, Jan. 26, 2025, in Philadelphia. (AP File)
10 hours ago

Tush Push Is the Hottest Topic at the NFL League Meetings

Help continue the work that gets you the news that matters most.

Search

Send this to a friend